These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 19890387)

  • 21. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
    Schwenk R; DeBot M; Porter M; Nikki J; Rein L; Spaccapelo R; Crisanti A; Wightman PD; Ockenhouse CF; Dutta S
    PLoS One; 2014; 9(10):e111020. PubMed ID: 25343487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver-Directed AAV8 Booster Vaccine Expressing
    Shahnaij M; Iyori M; Mizukami H; Kajino M; Yamagoshi I; Syafira I; Yusuf Y; Fujiwara K; Yamamoto DS; Kato H; Ohno N; Yoshida S
    Front Immunol; 2021; 12():612910. PubMed ID: 34248928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-investigation of the circumsporozoite protein-based induction of sterile immunity against Plasmodium berghei infection.
    Reed RC; Louis-Wileman V; Wells RL; Verheul AF; Hunter RL; Lal AA
    Vaccine; 1996 Jun; 14(8):828-36. PubMed ID: 8817831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibodies of three different immunoglobulin G isotypes produced by immunization with a synthetic peptide or native protein protect mice against challenge with Plasmodium yoelii sporozoites.
    Ak M; Bower JH; Hoffman SL; Sedegah M; Lees A; Carter M; Beaudoin RL; Charoenvit Y
    Infect Immun; 1993 Jun; 61(6):2493-7. PubMed ID: 8500885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge.
    Sauzet JP; Perlaza BL; Brahimi K; Daubersies P; Druilhe P
    Infect Immun; 2001 Feb; 69(2):1202-6. PubMed ID: 11160023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmodium berghei circumvents immune responses induced by merozoite surface protein 1- and apical membrane antigen 1-based vaccines.
    Yoshida S; Nagumo H; Yokomine T; Araki H; Suzuki A; Matsuoka H
    PLoS One; 2010 Oct; 5(10):e13727. PubMed ID: 21060850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy.
    Leitner WW; Bergmann-Leitner ES; Angov E
    Malar J; 2010 May; 9():145. PubMed ID: 20507620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective Efficacy Induced by Genetically Attenuated Mid-to-Late Liver-Stage Arresting Plasmodium berghei Δmrp2 Parasites.
    van der Velden M; Rijpma SR; Verweij V; van Gemert GJ; Chevalley-Maurel S; van de Vegte-Bolmer M; Franke-Fayard BM; Russel FG; Janse CJ; Sauerwein RW; Koenderink JB
    Am J Trop Med Hyg; 2016 Aug; 95(2):378-82. PubMed ID: 27296385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein.
    Khusmith S; Charoenvit Y; Kumar S; Sedegah M; Beaudoin RL; Hoffman SL
    Science; 1991 May; 252(5006):715-8. PubMed ID: 1827210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria.
    Rodrigues MM; Cordey AS; Arreaza G; Corradin G; Romero P; Maryanski JL; Nussenzweig RS; Zavala F
    Int Immunol; 1991 Jun; 3(6):579-85. PubMed ID: 1716146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations.
    Romero JF; Ibrahim GH; Renggli J; Himmelrich H; Graber P; Corradin G
    Parasite Immunol; 2007 Nov; 29(11):541-8. PubMed ID: 17944743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artesunate versus chloroquine infection-treatment-vaccination defines stage-specific immune responses associated with prolonged sterile protection against both pre-erythrocytic and erythrocytic Plasmodium yoelii infection.
    Peng X; Keitany GJ; Vignali M; Chen L; Gibson C; Choi K; Huang F; Wang R
    J Immunol; 2014 Aug; 193(3):1268-77. PubMed ID: 24958899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites.
    Charoenvit Y; Mellouk S; Cole C; Bechara R; Leef MF; Sedegah M; Yuan LF; Robey FA; Beaudoin RL; Hoffman SL
    J Immunol; 1991 Feb; 146(3):1020-5. PubMed ID: 1988490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.
    Hutchings CL; Birkett AJ; Moore AC; Hill AV
    Infect Immun; 2007 Dec; 75(12):5819-26. PubMed ID: 17908809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei.
    Weiss WR; Berzofsky JA; Houghten RA; Sedegah M; Hollindale M; Hoffman SL
    J Immunol; 1992 Sep; 149(6):2103-9. PubMed ID: 1517574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discriminating Protective from Nonprotective Plasmodium-Specific CD8+ T Cell Responses.
    Doll KL; Pewe LL; Kurup SP; Harty JT
    J Immunol; 2016 May; 196(10):4253-62. PubMed ID: 27084099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Merozoite surface protein 4/5 provides protection against lethal challenge with a heterologous malaria parasite strain.
    Goschnick MW; Black CG; Kedzierski L; Holder AA; Coppel RL
    Infect Immun; 2004 Oct; 72(10):5840-9. PubMed ID: 15385485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular and humoral immune effector mechanisms required for sterile protection against sporozoite challenge induced with the novel malaria vaccine candidate CelTOS.
    Bergmann-Leitner ES; Legler PM; Savranskaya T; Ockenhouse CF; Angov E
    Vaccine; 2011 Aug; 29(35):5940-9. PubMed ID: 21722682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmodium berghei circumsporozoite protein encapsulated in oligomannose-coated liposomes confers protection against sporozoite infection in mice.
    Terkawi MA; Kuroda Y; Fukumoto S; Tanaka S; Kojima N; Nishikawa Y
    Malar J; 2014 Nov; 13():426. PubMed ID: 25373617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment.
    Goodman AL; Forbes EK; Williams AR; Douglas AD; de Cassan SC; Bauza K; Biswas S; Dicks MD; Llewellyn D; Moore AC; Janse CJ; Franke-Fayard BM; Gilbert SC; Hill AV; Pleass RJ; Draper SJ
    Sci Rep; 2013; 3():1706. PubMed ID: 23609325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.